About us

OCT is the leading contract research organization in Russia. We have conducted hundreds of clinical trials in Eastern Europe, in both CEE and the CIS. Our team of 200+ professionals provides a full range of high-quality CRO services for Phase I-IV and BE studies, with therapeutic expertise in oncology, infectious disease, and all major therapeutic indications.


As pharmaceutical and biotechnology companies have turned toward outsourcing models in clinical research, OCT has established itself as one of the top contract research organizations worldwide. With strong local expertise and focus on quality, OCT ensures seamless clinical trial conduct and drug registration, on time and within budget. Our experienced team delivers a full range of CRO services including medical writing, consultancy, project management/monitoring, data management/biostatistics and turnkey service for clinical development.


Our portfolio spans all major therapeutic areas, including oncology, infectious disease, gastroenterology, cardiology and more. View All Therapeutic Area Experience.

300

completed projects
since 2005 

14+

years of
experience

1,600+

research
centers

45,000+

enrolled
patients

Experienced team


OCT is a team of over 200 clinical trial services professionals. Our clinical department consists of highly qualified specialists with medical, pharmaceutical
and chemical backgrounds. OCT is
managed by experienced clinical research experts who have contributed to the company’s development and growth
since its beginning.

Support and communication

The OCT team is always easy to reach:
we are an email or a phone call away and always respond within 24 hours. We
provide consulting on clinical trial strategy and design, site management and patient engagement solutions, regulatory and logistics support and timely updates on clinical trial progress.

Global Standards Compliant Studies

OCT works in full compliance with international standards (ICH GCP) and FDA/EMA requirements. Since 2005, we
have been guiding our sponsors through
the intricacies of conducting clinical trials
in Eastern Europe, both when dealing with the Ministry of Health of Russia and FDA or EMA. We have also developed our own
set of SOPs, which are regularly updated
by our Quality Assurance department.

Risk-management Approach

Our goal is to provide sponsors with full transparency from the first inquiry to the final step of the study. Prior to the project’s start, we conduct a thorough analysis and weigh of all the potential risks that might arise during the study, and prepare a risk management plan. In case risks occur, all the parties concerned are immediately informed and actions are taken in accordance with the plan.

Our partners